ABCB11 Gene Cholestasis benign recurrent intrahepatic type 2 Genetic Test
At DNA Labs UAE, we offer the ABCB11 Gene Cholestasis benign recurrent intrahepatic type 2 Genetic Test for individuals who suspect they may have this genetic disorder affecting their liver. This test can provide valuable information about the condition, including symptoms, diagnosis, and the cost of the test.
Test Details
The ABCB11 gene is associated with Cholestasis benign recurrent intrahepatic type 2, a genetic disorder that causes episodes of cholestasis, which is a reduction or blockage of bile flow in the liver. Common symptoms of this condition include recurrent itching, jaundice (yellowing of the skin and eyes), and elevated levels of certain liver enzymes.
Our NGS (Next-Generation Sequencing) genetic testing method allows us to analyze multiple genes simultaneously to identify genetic variations or mutations that may be responsible for Cholestasis benign recurrent intrahepatic type 2. By identifying specific mutations or variations in the ABCB11 gene, this test can provide a definitive diagnosis for individuals with this condition.
NGS genetic testing is a comprehensive and accurate method that can provide valuable insights into an individual’s genetic makeup. It can guide treatment decisions and provide information about the risk of passing the condition on to future generations.
Test Components and Price
Test Name: ABCB11 Gene Cholestasis benign recurrent intrahepatic type 2 Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood
Report Delivery: 3 to 4 Weeks
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information
Prior to undergoing the ABCB11 Gene Cholestasis benign recurrent intrahepatic type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by Cholestasis benign recurrent intrahepatic type 2. This information will help in accurately interpreting the test results.
At DNA Labs UAE, we prioritize providing accurate and reliable genetic testing services. Our team of experts is dedicated to assisting individuals in understanding their genetic makeup and providing appropriate guidance for their healthcare needs.
Test Name | ABCB11 Gene Cholestasis benign recurrent intrahepatic type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ABCB11 Gene Cholestasis benign recurrent intrahepatic type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Cholestasis benign recurrent intrahepatic type 2 |
Test Details |
The ABCB11 gene is associated with a condition called Cholestasis benign recurrent intrahepatic type 2. This is a genetic disorder that affects the liver and causes episodes of cholestasis, which is a reduction or blockage of bile flow. This condition is characterized by recurrent episodes of itching, jaundice (yellowing of the skin and eyes), and elevated levels of certain liver enzymes. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that can analyze multiple genes simultaneously to identify genetic variations or mutations that may be responsible for a particular condition. In the case of Cholestasis benign recurrent intrahepatic type 2, NGS genetic testing can be used to identify mutations or variations in the ABCB11 gene that may be causing the condition. By identifying the specific genetic mutation causing Cholestasis benign recurrent intrahepatic type 2, NGS genetic testing can provide a definitive diagnosis for individuals with this condition. This information can be useful for guiding treatment decisions and providing information about the risk of passing the condition on to future generations. |